VAISHALI — Vaishali Pharma Cashflow Statement
0.000.00%
- IN₹927.45m
- IN₹781.16m
- IN₹1.09bn
Annual cashflow statement for Vaishali Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 57.3 | 88.5 | 9.26 | 12.3 | 53.9 |
| Depreciation | |||||
| Non-Cash Items | 11.1 | 6.56 | 53.5 | 64.2 | 41.8 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -59.8 | -89.3 | -59.7 | -262 | -98.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 13.2 | 10.8 | 8.07 | -180 | 3.06 |
| Capital Expenditures | -8.65 | -2.97 | -1.11 | -3.05 | -4.59 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.18 | 5.79 | 13.1 | 1.17 | -48.7 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -8.47 | 2.82 | 12 | -1.88 | -53.3 |
| Financing Cash Flow Items | -25.4 | -19.8 | -17.4 | -15 | -19.4 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 4.17 | -17.3 | -14.2 | 185 | 46.1 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 8.89 | -3.71 | 5.93 | 2.65 | -4.13 |